Wolfgang Schüller

Director Financiero/CFO en EUCODIS Bioscience GmbH Deutschland .

Consumer Services

Commercial Services

Perfil

Wolfgang Schüller is currently the Chief Financial Officer at EUCODIS Bioscience GmbH Deutschland since 2006.
He has an undergraduate degree from the University of Gottingen and a doctorate degree from the University of Clausthal Technical.

Cargos activos de Wolfgang Schüller

Empresas	Cargo	Inicio
EUCODIS Bioscience GmbH Deutschland EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria.	Director Financiero/CFO	01/07/2006

Todos los cargos activos de Wolfgang Schüller

Formación de Wolfgang Schüller.

University of Gottingen	Undergraduate Degree
University of Clausthal Technical	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wolfgang Schüller.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
EUCODIS Bioscience GmbH Deutschland EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria.	Commercial Services